Adc Therapeutics (Switzerland)

CH-1066 (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

Oct 22 - Sep 26

Unlocking new drug targets through antibody-targeted protein degradation

EPSRC award to Imperial College London

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}